Caplin Point Laboratories Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
15108.08 Cr.
|
P/BV
|
5.94
|
Book Value (Rs.)
|
334.49
|
52 Week High/Low (Rs.)
|
2641/1599
|
FV/ML
|
2/1
|
P/E(X)
|
28.17
|
Bookclosure
|
12/09/2025
|
EPS (Rs.)
|
70.56
|
Div Yield (%)
|
0.30
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
No. of Equity Shares (in Lacs) | 760.12 | 759.42 | 759.03 | 757.89 | 756.43 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 15.20 | 15.19 | 15.18 | 15.16 | 15.13 |
Total Share Capital | 15.20 | 15.19 | 15.18 | 15.16 | 15.13 |
| | | | | |
Reserves and Surplus | 2760.71 | 2225.94 | 1775.35 | 1385.24 | 1155.90 |
Total Reserves and Surplus | 2760.71 | 2225.94 | 1775.35 | 1385.24 | 1155.90 |
Employees Stock Options | 0.00 | 0.00 | 15.37 | 8.95 | 14.80 |
Total Shareholders Funds | 2775.91 | 2241.13 | 1805.90 | 1409.35 | 1185.82 |
Hybrid/Debt/Other Securities | 74.58 | 74.58 | 74.58 | 74.58 | 0.00 |
Minority Interest | 35.90 | 31.12 | 26.79 | 25.95 | 17.54 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 1.16 |
Other Long Term Liabilities | 13.73 | 11.40 | 8.35 | 12.70 | 16.24 |
Long Term Provisions | 1.74 | 8.61 | 7.78 | 6.06 | 0.00 |
Total Non-Current Liabilities | 15.47 | 20.01 | 16.13 | 18.76 | 17.39 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 0.55 | 0.28 | 3.41 | 0.50 | 17.07 |
Trade Payables | 217.58 | 209.41 | 164.37 | 163.18 | 88.50 |
Other Current Liabilities | 64.28 | 110.50 | 99.94 | 41.44 | 37.20 |
Short Term Provisions | 23.58 | 11.09 | 0.28 | 2.56 | 0.09 |
Total Current Liabilities | 305.99 | 331.28 | 268.00 | 207.68 | 142.85 |
| | | | | |
Total Capital And Liabilities | 3207.85 | 2698.12 | 2191.40 | 1736.32 | 1363.61 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 534.51 | 440.14 | 268.87 | 278.04 | 298.10 |
Intangible Assets | 11.27 | 12.52 | 10.94 | 8.53 | 7.29 |
Capital Work-In-Progress | 139.22 | 116.62 | 220.48 | 15.41 | 13.82 |
Intangible Assets Under Development | 4.28 | 0.00 | 0.23 | 2.32 | 0.00 |
Fixed Assets | 689.28 | 569.28 | 500.52 | 304.30 | 319.22 |
Non-Current Investments | 279.13 | 137.63 | 70.52 | 37.01 | 0.66 |
Deferred Tax Assets [Net] | 2.23 | 12.55 | 13.83 | 6.21 | 0.00 |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 7.92 |
Other Non-Current Assets | 103.26 | 85.74 | 52.07 | 90.98 | 0.00 |
Total Non-Current Assets | 1073.90 | 805.20 | 636.94 | 438.50 | 327.80 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 311.33 | 237.98 | 159.17 | 51.97 | 10.54 |
Inventories | 336.10 | 363.04 | 288.22 | 227.31 | 179.00 |
Trade Receivables | 632.49 | 542.72 | 394.06 | 320.06 | 279.36 |
Cash And Cash Equivalents | 591.41 | 552.74 | 493.48 | 462.99 | 459.58 |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 98.90 |
OtherCurrentAssets | 262.62 | 196.44 | 219.53 | 235.49 | 8.44 |
Total Current Assets | 2133.95 | 1892.92 | 1554.46 | 1297.82 | 1035.81 |
| | | | | |
Total Assets | 3207.85 | 2698.12 | 2191.40 | 1736.32 | 1363.61 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 218.84 | 115.03 | 257.94 | 124.66 | 62.15 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Quoted Market Value | 0.00 | 1.09 | 0.00 | 0.00 | 0.00 |
Non-Current Investments Unquoted Book Value | 276.42 | 136.54 | 68.30 | 0.00 | 0.00 |
| | | | | |
CURRENT INVESTMENTS | | | | | |
Current Investments Quoted Market Value | 96.45 | 35.99 | 21.00 | 0.00 | 11.20 |
Current Investments Unquoted Book Value | 214.88 | 201.99 | 0.00 | 0.00 | 0.70 |